{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:42:24Z","timestamp":1787013744541,"version":"build-2736575974"},"reference-count":21,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Canadian guidelines recommend that patients with rheumatoid arthritis (RA) receive pneumococcal, influenza and shingles vaccinations. The aim of this study was to identify and understand vaccination rates in Canadian patients with RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted an observational study to evaluate uptake of herpes zoster (HZ), influenza and pneumonia vaccination in a cross\u2010section of patients with RA in Kingston, Ontario, Canada. Data were collected using a self\u2010administered questionnaire in patients attending at an academic rheumatology clinic. If vaccination was not received, the reason was established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety\u2010eight out of a total of 103 patients surveyed met the inclusion criteria and were evaluated: 72.4% had received the influenza vaccination in the past year encompassing a period of 2017\u20102019. Of the 27.6% who did not, the most common chosen reason was personal preference not to get vaccinated (55.6%). Regarding HZ, 18.4% had received vaccination. Of the 2 available types of vaccines, more participants received Zostavax (66.7%) as compared to Shringrix (33.3%). For those not vaccinated (81.6%), \u201cOther\u201d was the most chosen option (37.5%) with the reasons subsequently specified as cost, concern over interaction with treatment and waiting until age \u226565\u00a0years. In terms of pneumococcal vaccination, 36.7% were vaccinated, with the majority being vaccinated with Pneumovax\u201023 (63.9%) compared to Prevnar\u201013 (16.7%) or both (19.4%). Of the 63.3% of the participants who did not receive vaccination, the most cited reason was they did not know they should receive pneumococcal vaccination (48.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Vaccination rates among Canadian patients with RA are suboptimal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/1756-185x.13971","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T12:20:52Z","timestamp":1600863652000},"page":"1526-1533","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identifying perceptions and barriers regarding vaccination in patients with rheumatoid arthritis: A Canadian perspective"],"prefix":"10.1111","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0133-6510","authenticated-orcid":false,"given":"Babak","family":"Aberumand","sequence":"first","affiliation":[{"name":"Department of Medicine Queen\u2019s University Kingston Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey A.","family":"Dyck","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Medicine Queen\u2019s University Kingston Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveer","family":"Towheed","sequence":"additional","affiliation":[{"name":"Division of Rheumatology Department of Medicine Queen\u2019s University Kingston Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13103"},{"key":"e_1_2_10_3_1","volume-title":"The impact of arthritis in Canada: today and over the next 30 years","author":"Bombardier C","year":"2011"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes305"},{"key":"e_1_2_10_5_1","unstructured":"National Advisory Co. Canadian immunization guide. CMA Media Incorporated;2006."},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120165"},{"issue":"3","key":"e_1_2_10_7_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jbspin.2016.03.013","article-title":"Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and\/or immunosuppressive therapies for systemic autoimmune diseases: A cross\u2010sectional study","volume":"84","author":"Assala M","year":"2017","journal-title":"Joint, Bone, Spine"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2016.1242774"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3608-y"},{"issue":"1","key":"e_1_2_10_10_1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12891-016-1187-4","article-title":"A large two\u2010centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK","volume":"17","author":"Subesinghe S","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00296-016-3516-1","article-title":"Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age\u2010and sex\u2010matched controls: results of a claims data analysis","volume":"36","author":"Ramos AL","year":"2016","journal-title":"Rheumatol Int"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153848"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.065"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa078","article-title":"Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease\u2010modifying anti\u2010rheumatic drugs","author":"Nakafero G","year":"2020","journal-title":"Rheumatology"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23112"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40274-019-6057-5","article-title":"Shingrix cost effective versus Zostavax in Canada","volume":"832","author":"McGirr A","year":"2019","journal-title":"PharmacoEconomics & Outcomes News"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.12.003"},{"issue":"6","key":"e_1_2_10_18_1","first-page":"1","article-title":"Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review","volume":"38","author":"Boucher VG","year":"2018","journal-title":"Clin Rheumatol"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150984"},{"issue":"11","key":"e_1_2_10_20_1","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.24873","article-title":"Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert","volume":"61","author":"Ledwich LJ","year":"2009","journal-title":"Arthritis Care Res"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37716"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160179"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13971","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.13971","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T11:31:32Z","timestamp":1693827092000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/1756-185X.13971"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13971","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"2020-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}